Loading HERANBA price...
Peers are the listed companies in the exchange's own industry group: Pesticides & Agrochemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 22 Aug 2026), sales fell 15.3% from a year earlier to Rs 383 cr and profit rose 11.2% to Rs 7.0 cr.
- Sales grew 3 years running (Rs 1,070 cr in FY23 to Rs 1,595 cr in FY26).
- Profit fell 4 years running (Rs 189 cr in FY22 to -Rs 77.6 cr in FY26).
- Reported a loss in FY26.
- Operating margin fell from 12.6% in FY23 to 4.3% in FY26.
- Profit before interest covered interest -0.4 times in FY26 (Rs 50 cr of interest).
- Return on equity stayed under 10% from FY24 to FY26 (highest 4.1%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 20 results, the share rose on 5 and fell on 15, and moved by 3% or more on 15.
Q1 FY27: results filed 22 Aug 2026. The share went from its close on 21 Aug 2026 to its close on 24 Aug 2026 +8.17%.
Of every Rs 100 of sales in FY26, Rs 96 went on running costs, Rs 6.2 on depreciation, Rs 3.1 on interest and Rs 0.4 on tax; the year ended in a loss.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | -26.2% | 17.4% | 12.1% | 13.1% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 17.9% | 12.6% | 6.1% | 6.9% | 4.3% |
| Net marginProfit after everything, per Rs 100 of sales. | 13.0% | 8.7% | 2.7% | 0.2% | -4.9% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 11.5% | 4.1% | 0.3% | -10.1% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | - | 17.7% | 7.3% | 5.1% | -2.4% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | - | 0.11x | 0.19x | 0.41x | 0.74x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 63.2x | 21.8x | 5.2x | 1.6x | -0.4x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 1,970 Cr of assets. Its owners funded 39% of that and borrowings 29%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -96 Cr, spent Rs 92 Cr on plant and equipment, and cash fell by Rs 19 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| UPL UPL Limited | 42,056 cr | 20.6x | 1.2x | 5.6% | 11.2% | 0.53 | 4.4% | +10.5% | 1.16% |
| PIIND PI Industries Limited | 30,704 cr | 26.3x | 2.7x | 10.4% | 14.6% | 0.02 | 17.9% | -10.4% | 0.74% |
| SUMICHEM Sumitomo Chemical India Limited | 17,685 cr | 61.2x | 5.2x | 17.1% | 21.0% | 0.00 | 17.9% | +0.6% | 0.34% |
| SHARDACROP Sharda Cropchem Limited | 5,688 cr | 9.1x | 1.8x | 20.0% | 25.3% | 0.00 | 11.7% | +9.0% | 1.91% |
| DHANUKA Dhanuka Agritech Limited | 3,709 cr | 14.0x | 2.2x | 15.9% | 22.1% | 0.00 | 13.7% | -12.6% | 0.24% |
| RALLIS Rallis India Limited | 3,664 cr | 17.6x | 1.8x | 10.5% | 12.3% | 0.00 | 7.2% | +6.8% | 1.34% |
| NACLIND NACL Industries Limited | 2,650 cr | 221.8x | 3.9x | 1.8% | 7.8% | 0.44 | 0.8% | -14.5% | 0.00% |
| BHAGCHEM Bhagiradha Chemicals & Industries Limited | 2,512 cr | 91.4x | 3.6x | 3.9% | 4.4% | 0.33 | 4.5% | +57.6% | 0.08% |
| GSPCROP GSP Crop Science Limited | 2,010 cr | - | 2.6x | - | 20.2% | 0.34 | - | - | 0.15% |
| INSECTICID Insecticides (India) Limited | 1,522 cr | 12.2x | 1.3x | 10.3% | 16.1% | 0.12 | 6.1% | -11.5% | 0.38% |
| ASTEC Astec LifeSciences Limited | 1,455 cr | - | 3.7x | -17.0% | -10.5% | 1.15 | -15.1% | -8.3% | 0.00% |
| MOL Meghmani Organics Limited | 1,397 cr | 21.7x | 0.9x | 4.2% | 8.6% | 0.47 | 3.0% | -11.5% | 0.00% |
| IPL India Pesticides Limited | 1,314 cr | 12.2x | 1.3x | 10.7% | 16.2% | 0.11 | 10.4% | -8.5% | 0.66% |
| PUNJABCHEM Punjab Chemicals & Crop Protection Limited | 1,196 cr | 18.3x | 2.8x | 15.4% | 20.7% | 0.36 | 6.2% | +8.7% | 0.31% |
| ADVANCE Advance Agrolife Limited | 845 cr | 15.4x | 2.7x | 15.8% | 17.2% | 0.31 | 6.1% | +96.0% | 0.00% |
| DHARMAJ Dharmaj Crop Guard Limited | 811 cr | 13.5x | 1.8x | 13.4% | 17.6% | 0.29 | 5.2% | +4.1% | 0.00% |
| HERANBA Heranba Industries Limited | 585 cr | - | 0.8x | -10.0% | -2.4% | 0.74 | -5.0% | -15.3% | 0.68% |
| SHIVALIK Shivalik Rasayan Limited | 494 cr | 36.2x | 0.8x | 3.3% | 4.9% | 0.19 | 5.2% | +7.9% | 0.43% |
| BHARATRAS Bharat Rasayan Limited | 388 cr | 6.8x | 0.3x | 11.0% | 15.1% | 0.00 | 11.6% | -10.4% | 0.16% |
| IGCL Indogulf Cropsciences Limited | 361 cr | 11.0x | 0.8x | 8.4% | 14.7% | 0.39 | 5.6% | -11.0% | 0.00% |
| BESTAGRO Best Agrolife Limited | 32 cr | 0.8x | 0.0x | 3.9% | 7.6% | 0.56 | 2.3% | +3.9% | 21.99% |
| SIKKO Sikko Industries Limited | 10 cr | 3.5x | 0.1x | 7.1% | 8.1% | 0.14 | 9.4% | -2.3% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 17.9% to 4.3% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
2024 paid Rs 1.25 per share, about Rs 855 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-09-25 | NK SECURITIES RESEARCH PRIVATE LIMITED | SELL | 2,06,732 | 193.59 | Rs 4 Cr |
| 2026-09-25 | NK SECURITIES RESEARCH PRIVATE LIMITED | BUY | 2,06,732 | 193.36 | Rs 4 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.